+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Career Development Bridge Funding Award: K Supplement

Rheumatology Research Foundation

A supplement to the NIH or VA career development awards

Purpose
Encourage junior investigators to expand promising research by providing additional support to cover research costs and help investigators become independent

Award Amount
$100,000

Award Term
2 Years

Application Deadline
Applications are due August 3, 2026 by 5 PM ET

AI Based Application Success Predictor

🦴 1. Strong Focus on Rheumatic & Musculoskeletal Diseases (Non-Negotiable)

Projects must directly address:
- Rheumatic diseases such as:
  - Rheumatoid arthritis
  - Lupus
  - Gout, vasculitis, spondyloarthritis

👉 Non-rheumatology topics → not competitive

🎯 2. Clear Clinical Impact on Patient Care (Top Predictor)

Core mission:
- Improve treatment, outcomes, and quality of life for patients
Successful proposals:
- Demonstrate real-world clinical relevance

👉 Key question:
“Will this improve care for patients with rheumatic disease?”

🔄 3. Translational & Clinically Relevant Research (Critical)

RRF funds:
- Basic, translational, and clinical research
But prioritizes:
- Research that leads to better diagnosis or treatment

👉 Pure basic science without application is less competitive

👩‍🔬 4. Early-Career Investigator Development (Major Priority)

A large portion of funding supports:
- Residents, fellows, and junior faculty
Goal:
- Build the next generation of rheumatology researchers

👉 Career trajectory is heavily weighted

🤝 5. Strong Mentorship & Training Environment

Many awards require:
- Structured mentorship plans
Mentors should:
- Guide research + career development

👉 Weak mentorship is a common rejection factor

🧪 6. Feasible, Well-Structured Study Design

Grants are typically:
- Pilot or mid-scale projects
Must include:
- Clear aims
- Defined methods
- Realistic timelines

👉 Overly ambitious proposals are often rejected

📈 7. Potential for Future NIH/External Funding (Key Differentiator)

RRF funding is:
- Career-launch / bridge funding
Designed to:
- Help investigators secure:
  - NIH or major grants

👉 Projects that generate preliminary data score higher

🔬 8. Scientific Merit & Innovation

Proposals undergo:
- Rigorous peer review (NIH-style)
Must demonstrate:
- Strong hypothesis
- Novelty
- Methodological rigor

🧠 9. Alignment with Priority Disease Areas

Higher success in:
- Lupus
- Spondyloarthritis
- Dermatomyositis
Special funding calls (NOSI topics) often exist

👉 Aligning with highlighted topics improves competitiveness

🌍 10. Broad Impact on Rheumatology Practice & Workforce

RRF uniquely funds:
- Education + workforce development + research
Projects that:
- Improve access to care
- Strengthen rheumatology workforce
  → are valued

📊 Summary: Key Predictors (Ranked)

Highest impact factors:

Rheumatology-specific focus
Clinical/patient impact
Translational relevance

Moderate predictors:
4. Early-career development
5. Mentorship quality
6. Feasibility

Supporting factors:
7. Scientific merit
8. Priority topic alignment
9. Future funding potential

💡 Insider Insight

Compared to NIH:

Rheumatology Research Foundation is:
👉 career-development + disease-specific funder
👉 strongly focused on building the rheumatology workforce

👉 Winning formula:
Rheumatology-focused idea + clear clinical impact + strong mentorship + feasible pilot study

✔️ What wins:

Clinically relevant rheumatology research
Early-career investigators with strong mentors
Projects generating preliminary data for NIH

❌ What struggles:

Non-rheumatology topics
Pure basic science
Weak career development plan

Specialties

Rheumatology

Eligibility Requirements

To be eligible for this award, the applicant must:

Applicant must meet all eligibility requirements as outlined in the Awards and Grants policies.

Applicants must be ACR or ARP members with an MD, DO, PhD or equivalent doctoral level degree from an accredited institution.

* Non-MD/DOs submitting basic science projects must clearly demonstrate direct applicability to rheumatic diseases, relevance to the Foundation’s mission and demonstrate a clear future career path in the field of rheumatology.

Previous recipients of this award are not eligible to apply.

Applicant is not eligible to receive funding from the Foundation’s Scientist Development Award or Investigator Award during the Bridge Funding Award term

In addition to an excellent application, applicants must be capable of becoming independent researchers with a clear and firm institutional commitment to their career development, including a faculty position and other supporting resources

Sponsor Details

Sponsor Institute/Organizations: Rheumatology Research Foundation

Sponsor Type: Corporate/Non-Profit

Address: 2200 Lake Boulevard NE | Atlanta, GA 30319 | (404) 365-1373

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity